Dow Jones

38,807.33

0.25%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

AORT

Artivion (AORT)

Artivion Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:AORT

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
03/06/2024	07:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
30/05/2024	15:12	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NYSE:AORT	Artivion Inc
17/05/2024	15:14	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AORT	Artivion Inc
10/05/2024	17:04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AORT	Artivion Inc
07/05/2024	11:07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:AORT	Artivion Inc
06/05/2024	15:05	PR Newswire (US)	Artivion Reports First Quarter 2024 Financial Results	NYSE:AORT	Artivion Inc
29/04/2024	07:05	PR Newswire (US)	Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting	NYSE:AORT	Artivion Inc
22/04/2024	15:10	PR Newswire (US)	Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results	NYSE:AORT	Artivion Inc
01/04/2024	15:10	PR Newswire (US)	Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference	NYSE:AORT	Artivion Inc
11/03/2024	16:45	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NYSE:AORT	Artivion Inc
06/03/2024	15:10	PR Newswire (US)	Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference	NYSE:AORT	Artivion Inc
15/02/2024	15:05	PR Newswire (US)	Artivion Reports Fourth Quarter and Full Year 2023 Financial Results	NYSE:AORT	Artivion Inc
14/02/2024	05:18	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:AORT	Artivion Inc
01/02/2024	15:10	PR Newswire (US)	Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results	NYSE:AORT	Artivion Inc
30/01/2024	19:12	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	NYSE:AORT	Artivion Inc
29/01/2024	07:25	PR Newswire (US)	Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting	NYSE:AORT	Artivion Inc
18/01/2024	15:05	PR Newswire (US)	Artivion Obtains $350 Million in Senior Secured Credit Facilities	NYSE:AORT	Artivion Inc
08/12/2023	08:14	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:AORT	Artivion Inc
06/12/2023	15:15	PR Newswire (US)	Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer	NYSE:AORT	Artivion Inc
09/11/2023	07:25	PR Newswire (US)	Artivion Announces Completion of Enrollment in PERSEVERE Trial	NYSE:AORT	Artivion Inc
08/11/2023	15:05	PR Newswire (US)	Artivion to Participate in Upcoming Investor Conferences	NYSE:AORT	Artivion Inc
02/11/2023	15:05	PR Newswire (US)	Artivion Reports Third Quarter 2023 Financial Results	NYSE:AORT	Artivion Inc
19/10/2023	15:10	PR Newswire (US)	Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results	NYSE:AORT	Artivion Inc
05/10/2023	15:15	PR Newswire (US)	Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin	NYSE:AORT	Artivion Inc
05/10/2023	15:05	PR Newswire (US)	Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting	NYSE:AORT	Artivion Inc
26/09/2023	07:25	PR Newswire (US)	Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference	NYSE:AORT	Artivion Inc
14/09/2023	07:05	PR Newswire (US)	Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase	NYSE:AORT	Artivion Inc
03/08/2023	15:05	PR Newswire (US)	Artivion Reports Second Quarter 2023 Financial Results	NYSE:AORT	Artivion Inc
20/07/2023	07:25	PR Newswire (US)	Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2023 Financial Results	NYSE:AORT	Artivion Inc
09/06/2023	15:28	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NYSE:AORT	Artivion Inc